Antisense and RNAi Therapeutics Drug - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757931
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 131
-
According to Ample Market Research, the global market for Antisense and RNAi Therapeutics Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Antisense and RNAi Therapeutics Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Antisense and RNAi Therapeutics Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Neuromuscular Diseases grew percent to account for percent of the total market sales, and ATTR grew percent.
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
This report studies and analyses global Antisense and RNAi Therapeutics Drug status and future trends, to help determine the Antisense and RNAi Therapeutics Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Antisense and RNAi Therapeutics Drug, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Antisense and RNAi Therapeutics Drug market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Antisense and RNAi Therapeutics Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Antisense and RNAi Therapeutics Drug by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Antisense and RNAi Therapeutics Drug key consuming regions, consumption value and demand structure
(5) Antisense and RNAi Therapeutics Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Market segment by Type, covers
Antisense Oligonucleotide
Aptamer
Other
Market segment by Application, can be divided into
Neuromuscular Diseases
ATTR
Hepatic VOD
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Antisense and RNAi Therapeutics Drug product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Antisense and RNAi Therapeutics Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Antisense and RNAi Therapeutics Drug market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Antisense and RNAi Therapeutics Drug industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Antisense and RNAi Therapeutics Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Antisense and RNAi Therapeutics Drug Definition
1.2 Global Antisense and RNAi Therapeutics Drug Market Size and Forecast
1.3 China Antisense and RNAi Therapeutics Drug Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Antisense and RNAi Therapeutics Drug Market Size: China VS Global Growth Rate, 2018-2029
1.6 Antisense and RNAi Therapeutics Drug Market Dynamics
1.6.1 Antisense and RNAi Therapeutics Drug Market Drivers
1.6.2 Antisense and RNAi Therapeutics Drug Market Restraints
1.6.3 Antisense and RNAi Therapeutics Drug Industry Trends
1.6.4 Antisense and RNAi Therapeutics Drug Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Antisense and RNAi Therapeutics Drug, Global Market Share by Company, 2018-2023
2.2 Global Antisense and RNAi Therapeutics Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Antisense and RNAi Therapeutics Drug Concentration Ratio
2.4 Global Antisense and RNAi Therapeutics Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Antisense and RNAi Therapeutics Drug Major Companies Product Type
2.6 Head Office and Antisense and RNAi Therapeutics Drug Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Antisense and RNAi Therapeutics Drug, China Market Share by Company, 2018-2023
3.2 China Antisense and RNAi Therapeutics Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Antisense and RNAi Therapeutics Drug Industry Chain
4.2 Antisense and RNAi Therapeutics Drug Upstream Analysis
4.2.1 Antisense and RNAi Therapeutics Drug Core Raw Materials
4.2.2 Main Manufacturers of Antisense and RNAi Therapeutics Drug Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Antisense and RNAi Therapeutics Drug Production Mode
4.6 Antisense and RNAi Therapeutics Drug Procurement Model
4.7 Antisense and RNAi Therapeutics Drug Industry Sales Model and Sales Channels
4.7.1 Antisense and RNAi Therapeutics Drug Sales Model
4.7.2 Antisense and RNAi Therapeutics Drug Typical Distributors
5 Sights by Type5.1 Antisense and RNAi Therapeutics Drug Classification
5.1.1 Antisense Oligonucleotide
5.1.2 Aptamer
5.1.3 Other5.2 By Type, Global Antisense and RNAi Therapeutics Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Antisense and RNAi Therapeutics Drug Consumption Value, 2018-2029
6 Sights by Application6.1 Antisense and RNAi Therapeutics Drug Segment by Application
6.1.1 Neuromuscular Diseases
6.1.2 ATTR
6.1.3 Hepatic VOD
6.1.4 Other6.2 By Application, Global Antisense and RNAi Therapeutics Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Antisense and RNAi Therapeutics Drug Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Antisense and RNAi Therapeutics Drug Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Antisense and RNAi Therapeutics Drug Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Antisense and RNAi Therapeutics Drug & Forecasts, 2018-2029
7.3.2 By Country, North America Antisense and RNAi Therapeutics Drug Market Size Market Share7.4 Europe
7.4.1 Europe Antisense and RNAi Therapeutics Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Antisense and RNAi Therapeutics Drug Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Antisense and RNAi Therapeutics Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Antisense and RNAi Therapeutics Drug Market Size Market Share7.6 South America
7.6.1 South America Antisense and RNAi Therapeutics Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Antisense and RNAi Therapeutics Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Antisense and RNAi Therapeutics Drug Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Antisense and RNAi Therapeutics Drug Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.3.2 By Type, U.S. Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.4.2 By Type, Europe Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.5.2 By Type, China Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.6.2 By Type, Japan Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.7.2 By Type, South Korea Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.9.2 By Type, India Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Antisense and RNAi Therapeutics Drug Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Biogen
9.1.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.1.2 Biogen Company Profile and Main Business
9.1.3 Biogen Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.1.4 Biogen Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.1.5 Biogen Recent Developments9.2 Sarepta Therapeutics
9.2.1 Sarepta Therapeutics Company Information, Head Office, Market Area and Industry Position
9.2.2 Sarepta Therapeutics Company Profile and Main Business
9.2.3 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.2.4 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.2.5 Sarepta Therapeutics Recent Developments9.3 Jazz Pharmaceuticals
9.3.1 Jazz Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.3.2 Jazz Pharmaceuticals Company Profile and Main Business
9.3.3 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.3.4 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.3.5 Jazz Pharmaceuticals Recent Developments9.4 Bausch & Lomb
9.4.1 Bausch & Lomb Company Information, Head Office, Market Area and Industry Position
9.4.2 Bausch & Lomb Company Profile and Main Business
9.4.3 Bausch & Lomb Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.4.4 Bausch & Lomb Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.4.5 Bausch & Lomb Recent Developments9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.5.2 Alnylam Pharmaceuticals Company Profile and Main Business
9.5.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.5.4 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.5.5 Alnylam Pharmaceuticals Recent Developments9.6 Dynavax Technologies
9.6.1 Dynavax Technologies Company Information, Head Office, Market Area and Industry Position
9.6.2 Dynavax Technologies Company Profile and Main Business
9.6.3 Dynavax Technologies Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.6.4 Dynavax Technologies Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.6.5 Dynavax Technologies Recent Developments
9.7 Kastle therapeutics
9.7.1 Kastle therapeutics Company Information, Head Office, Market Area and Industry Position
9.7.2 Kastle therapeutics Company Profile and Main Business
9.7.3 Kastle therapeutics Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.7.4 Kastle therapeutics Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.7.5 Kastle therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Company Information, Head Office, Market Area and Industry Position
9.8.2 Akcea Therapeutics Company Profile and Main Business
9.8.3 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Models, Specifications and Application
9.8.4 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Revenue and Gross Margin, 2018-2023
9.8.5 Akcea Therapeutics Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Antisense and RNAi Therapeutics Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Antisense and RNAi Therapeutics Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Antisense and RNAi Therapeutics Drug Global and China Top Players has a wide range of applications, including
The Antisense and RNAi Therapeutics Drug Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
As the shift to value addition continues, companies in the Antisense and RNAi Therapeutics Drug Global and China Top Players Market face the dual challenge of improving interoperability to optimize performance and experience.
The Antisense and RNAi Therapeutics Drug Global and China Top Players analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.
